Literature DB >> 22858793

Surgical treatment of a patient with lung cancer metastasized to the spine with EGFR mutation: A case report.

Ahmed Adel Aoude1, Louis-Philippe Amiot.   

Abstract

INTRODUCTION: The prognosis of patients with lung cancer metastasis to the spine is not very promising and a palliative approach is often suggested by scales such as the Tomita score. The choice of surgery for these patients is questionable based on the aggressiveness of the disease. However, certain patient characteristics can be sought out to determine if surgery is indicated. PRESENTATION OF CASE: Here, we present a case of a 59 year old male which consulted for back pain, numbness of the upper left thigh, and weakness corresponding to an L2 lesion. It was later discovered that he was suffering from non small cell lung cancer (adenocarcinoma) with a single metastasis to the spine at the level of L2. The patient also presented an EGFR mutation. Thus, the patient presented two good prognosis characteristics: adenocarcinoma and an EGFR mutation. DISCUSSION: An aggressive treatment was chosen. This included an EGFR inhibitor, surgical treatment, and radiotherapy thereafter. The patient had no complications due to surgery and to date, the patient has survived over 12 months and is free of any symptoms. This case demonstrates that surgical intervention can be considered for certain patients with lung cancer metastasized to the spine.
CONCLUSION: This case demonstrates that surgical intervention can be considered for certain patients with lung cancer metastasized to the spine. We hope spine surgeons in general will start verifying the EGFR mutation status of adenocarcinoma lung cancer patients to determine if surgery is indicated.
Copyright © 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Year:  2012        PMID: 22858793      PMCID: PMC3421144          DOI: 10.1016/j.ijscr.2012.07.002

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


  11 in total

1.  Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers.

Authors:  Y Omoto; Y Kobayashi; K Nishida; E Tsuchiya; H Eguchi; K Nakagawa; Y Ishikawa; T Yamori; H Iwase; Y Fujii; M Warner; J A Gustafsson; S I Hayashi
Journal:  Biochem Biophys Res Commun       Date:  2001-07-13       Impact factor: 3.575

2.  Estrogen receptor signaling pathways in human non-small cell lung cancer.

Authors:  Diana C Márquez-Garbán; Hsiao-Wang Chen; Michael C Fishbein; Lee Goodglick; Richard J Pietras
Journal:  Steroids       Date:  2007-02-05       Impact factor: 2.668

3.  The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers.

Authors:  Chen-Tu Wu; Yih-Leong Chang; Jin-Yuan Shih; Yung-Chie Lee
Journal:  J Thorac Cardiovasc Surg       Date:  2005-10       Impact factor: 5.209

4.  Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence.

Authors:  Tetsuya Mitsudomi; Takayuki Kosaka; Hideki Endoh; Yoshitsugu Horio; Toyoaki Hida; Shoichi Mori; Shunzo Hatooka; Masayuki Shinoda; Takashi Takahashi; Yasushi Yatabe
Journal:  J Clin Oncol       Date:  2005-02-28       Impact factor: 44.544

5.  Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.

Authors:  Laura P Stabile; Jennifer S Lyker; Christopher T Gubish; Weiping Zhang; Jennifer R Grandis; Jill M Siegfried
Journal:  Cancer Res       Date:  2005-02-15       Impact factor: 12.701

6.  [Two lung adenocarcinoma patients with multiple brain metastasis treated with Gefitinib and surviving more than 2 years].

Authors:  Wataru Matsuyama; Masuki Yamamoto; Kentarou Machida; Hideo Mitsuyama; Masaki Watanabe; Ikkou Higashimoto; Mitsuhiro Osame; Kimiyoshi Arimura
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2006-09

7.  Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trial.

Authors:  Roy S Herbst; Anne-Marie Maddox; Mace L Rothenberg; Eric J Small; Eric H Rubin; Jose Baselga; Federico Rojo; Waun Ki Hong; Helen Swaisland; Steven D Averbuch; Judith Ochs; Patricia Mucci LoRusso
Journal:  J Clin Oncol       Date:  2002-09-15       Impact factor: 44.544

8.  EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Authors:  J Guillermo Paez; Pasi A Jänne; Jeffrey C Lee; Sean Tracy; Heidi Greulich; Stacey Gabriel; Paula Herman; Frederic J Kaye; Neal Lindeman; Titus J Boggon; Katsuhiko Naoki; Hidefumi Sasaki; Yoshitaka Fujii; Michael J Eck; William R Sellers; Bruce E Johnson; Matthew Meyerson
Journal:  Science       Date:  2004-04-29       Impact factor: 47.728

9.  Expression of estrogen receptors alpha and beta in human lung tissue and cell lines.

Authors:  Steen Mollerup; Kjersti Jørgensen; Gisle Berge; Aage Haugen
Journal:  Lung Cancer       Date:  2002-08       Impact factor: 5.705

10.  Predictors of survival in patients with bone metastasis of lung cancer.

Authors:  Hideshi Sugiura; Kenji Yamada; Takahiko Sugiura; Toyoaki Hida; Tetsuya Mitsudomi
Journal:  Clin Orthop Relat Res       Date:  2008-01-03       Impact factor: 4.176

View more
  4 in total

1.  Clinical outcome of posterior fixation surgery in patients with vertebral metastasis of lung cancer.

Authors:  Tomoyuki Igarashi; Keigo Okamoto; Koji Teramoto; Ryosuke Kaku; Keiko Ishida; Keiko Ueda; Yo Kawaguchi; Tetsuo Hori; Masayuki Hashimoto; Shoji Kitamura; Noriaki Tezuka; Jun Hanaoka
Journal:  Mol Clin Oncol       Date:  2017-03-17

2.  Evaluation of the relevance of surgery in a retrospective case series of patients who underwent the surgical treatment of a symptomatic spine metastasis from lung cancer.

Authors:  Fahed Zairi; Mélodie-Anne Karnoub; Marie-Hélène Vieillard; Alkis Bouras; Paulo Marinho; Mohamed Allaoui; Patrick Devos; Richard Assaker
Journal:  Eur Spine J       Date:  2016-01-28       Impact factor: 3.134

3.  Long-term survival of a patient with lung cancer metastasis to the spine following surgical treatment combined with radiation and epithelial growth factor receptor inhibitor therapy: A case report.

Authors:  Songfeng Xu; Xiuchun Yu; Ming Xu
Journal:  Exp Ther Med       Date:  2014-11-07       Impact factor: 2.447

4.  Total en bloc thoracic and lumbar spondylectomy for non-small cell lung cancer with favorable prognostic indicators: is it merely indicated for solitary spinal metastasis?

Authors:  Jong-Hwa Park; Seung-Jae Hyun; Ki-Jeong Kim; Tae-Ahn Jahng
Journal:  J Korean Neurosurg Soc       Date:  2014-11-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.